PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that data related to the company’s Corus® CAD gene expression test will be presented at the American College of Cardiology’s (ACC’s) 61st Annual Scientific Sessions & Expo taking place March 24-27 in Chicago.
